|Santa Barbara Based And Worldwide Distributed Protocol Receives Patent|
Santa Barbara, California- 2/7/2010- The Wiley Protocol, headquartered in Santa Barbara, CA. has received patent #7,879,830. Ten years after the first in lab experiments with progesterone and breast cancer cells, seven years after the publication of Sex, Lies and Menopause and the creation of the Wiley Protocol for women, the USPTO has recognized the Wiley Protocol as unique with its recent patent ruling : The Wiley Protocol # 7,879,830.
Patented for treatment using a 28-day biomimetic, variable dose cycling bio-identical hormone therapy protocol, this ground-breaking ruling paves the way for greater standardization of compounded medicines, including standardized dose modification, which increases safety for women, and complete protection for patients who wish to utilize WP for therapy. Patients can now be assured they are getting the real Protocol made by trained pharmacists and dispensed by knowledgeable physicians.
T.S. Wiley commented about the patent, “This is a land mark moment for singular scientists everywhere. Until this moment, the only patented treatments for the bioidentical hormone treatment of menopause and related disease states have come from big pharmaceutical companies. The Wiley Protocol for Women is the beginning of real Feminist Medicine."
It's a nod toward the unique nature, long term clinical results, and peer-reviewed science driven approach that the Wiley Protocol entails. We will continue to study BHRT in this now patent-protected environment for the good of all women.
Wiley’s revolutionary discovery that it may be the rhythm that matters in the accurate physiological replacement of hormones may have important implications across a wide range of areas, from the treatment of menopause and anti-aging to other diseases of
Wiley Systems, Inc. founded in Santa Barbara, CA in 2005, began as a project to unite doctors and pharmacists in a common goal to standardize bio-identical hormones for academic research.
The Wiley Protocol(R) is a trademarked, patent protected bio-identical hormone replacement therapy (HRT) delivery system consisting of biomimetic estradiol and progesterone in a topical cream preparation – dosed to mimic the natural hormones produced by a woman's body when she was in her prime. The Wiley Protocol was developed by T.S. Wiley, a popular author and frequent speaker at medical seminars around the world.